Medical supply wholesalers benefit from downstream markets' robust demand for innovative medical devices and products. Many healthcare providers (physicians, hospitals and other institutions) have purchased these innovative products from industry wholesalers to attract patients. Substituting these new and more expensive products, rising prices for existing products and more per-patient use of medical supplies have contributed to solid wholesaler revenue growth. And since most wholesalers specialize in specific product markets, they can better exploit product introductions. Despite the pandemic's impact on revenue volatility from supply chain interruption, revenue is expected to strengthen at a CAGR of 1.9% to $33.9 through 2024, with revenue increasing 2.5% in 2024 alone and profit holding at 7.9%. Demographic shifts and market competitive pressures have influenced revenue and the impact of innovations. Some wholesalers have enhanced profit by expanding operations (device maintenance) to include value-added services for novel products. Shifting lifestyle trends have spurred the development of and been reinforced by new medical technology, boosting the variety of products wholesalers deliver to the marketplace. However, competitive market forces have muted revenue growth, exerting downward pricing pressure. Wholesalers are notably concentrated in highly populated regions, facing stiffer competition that adds downward pressure on prices wholesalers can charge for the newer products. Medical research and development and new product development at the manufacturing stage will likely continue to benefit downstream wholesalers. However, as medical device manufacturers consolidate and healthcare providers form group purchasing organizations (GPOs), wholesalers' negotiating power will be squeezed. Mergers or expansion of operations may be needed to counter the profit squeeze while gaining economies of scale. In addition, wholesalers will implement initiatives focused on improving efficiency, including investing in warehouse management and demand forecasting systems alongside consolidation activity. Direct-to-consumer sales will intensify competition, challenging revenue, depending on the product. With various favourable product tailwinds but competitive headwinds, revenue is forecast to climb at a CAGR of 2.6% to $38.6 billion through 2029.

Canada Clinical Nutrition Market size was valued at USD 2.1 Billion in 2024 and is projected to reach USD 3.5 Billion by 2032, growing at a CAGR of 6.6% from 2026 to 2032. Key Market Drivers:Aging Population: As per Statistics Canada, the number of Canadians aged 65 and up reached 7.3 million in 2023, with projections indicating that this figure will rise to 9.8 million by 2031. Healthcare spending on nutritional support for this demographic increasing by 27% between 2021 and 2023.Rising Chronic Disease Prevalence: The Public Health Agency of Canada reports that 44% of Canadian adults now have at least one chronic condition requiring nutritional management, with diabetes affecting approximately 3.8 million Canadians in 2023, up from 3.2 million in 2020.

This study examined the experiences of Canadian undergraduate students accessing mental healthcare between November 2022 to February 2023. We specifically assessed the impact of social determinants of health (i.e., gender, socioeconomic status, immigration status, English as a second language). Participants were recruited through social media platforms and by undergraduate program administrators at Canadian universities. Participants were asked to provide demographic information, answer questions about their experiences accessing mental healthcare, and to complete the mental health continuum short form (MHC-SF). Descriptive statistics and linear regression models were used to assess the association between MHC-SF and social determinants of health (e.g.: demographics, language, immigration status). Of 1098 students invited to participate, 365 participants completed the study (completion rate: 33.2%). Their mean age (SD) was 21.4 (4.6) years; 73.6% were female and 45.7% identified as non-White. Overall, the mean (SD) MHC-SF score of participants was 2.36 (0.99) out of 5. Students with low SES had lower MHC-SF scores (mean 2.08 vs 2.45; p = 0.003). The multivariable analysis showed that low SES (β -0.36; 95%CI: -0.60 to -0.12) and female gender (β -0.29; 95%CI: -0.58 to -0.012) were associated with lower MHC-SF scores. Additionally, being White was associated with higher MHC-SF scores (β -0.29; 95%CI: -0.44 to 0.54). Age, English as a second language, and immigration status were not significant predictors of mental health. High levels of stress, negative perceptions of the mental healthcare system, and limited access were the more common reported themes in the qualitative analysis. In our cohort, university students from across Canada had low MHC scores. Social determinants of health (e.g., low SES, being non-White, and identifying as a woman) were independent predictors of low MCH scores. Further studies are needed to identify specific groups at higher risk as well as strategies to overcome the suboptimal mental health among Canadian students.

Snapshot img

Medical Technologies Market Size 2025-2029

The medical technologies market size is forecast to increase by USD 346.4 billion, at a CAGR of 8% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of diseases and the growing use of connected devices and technologies. Public health surveillance and digital therapeutics are transforming disease prevention and treatment, while speech therapy and behavioral health technologies are addressing the growing need for mental health services. The advancements in medical technology are enabling early disease detection and diagnosis, leading to improved patient outcomes and reduced healthcare costs. Furthermore, the integration of technology in healthcare is enhancing the overall patient experience and facilitating remote monitoring and telemedicine services. However, the market faces challenges in the form of declining reimbursement and cost containment measures.
Additionally, regulatory requirements and compliance issues can pose significant challenges for market participants. Companies must navigate these obstacles by focusing on innovation, cost reduction, and regulatory compliance to remain competitive and capitalize on the market's potential. As healthcare costs continue to rise, payers are increasingly looking for cost-effective solutions, which may limit the adoption of advanced medical technologies. Medical regulations and data analytics shape the industry, ensuring compliance and informed decision-making.

What will be the Size of the Medical Technologies Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in various sectors. Supply chain management optimizes the distribution of surgical instruments, therapeutic devices, and pharmaceutical research products. Robotics in surgery and laser technology enhance minimally invasive procedures, while healthcare IT streamlines medical billing and insurance claims processing. Regulatory affairs ensure safety and efficacy of medical devices, from implantable devices to drug delivery systems. Patient engagement is facilitated through wearable sensors and remote patient monitoring, enabling preventive medicine and chronic disease management. Predictive analytics and precision medicine offer personalized treatment plans, revolutionizing disease management.

Sterilization techniques and hospital management systems maintain high standards of hygiene and efficiency. Medical lasers and radiation therapy provide precise interventions, while medical imaging software and diagnostic imaging offer accurate diagnoses. The ongoing unfolding of market activities shapes the landscape of medical technologies, with distribution channels and public health remaining key considerations. Regenerative medicine holds great potential, with ongoing clinical trials and nanotechnology in medicine pushing the boundaries of healing.

How is this Medical Technologies Industry segmented?

The medical technologies industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Medical devices
  In-vitro diagnostics


End-user

  Hospitals
  Clinics
  Others


Component

  Hardware
  Services
  Software


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Application Insights

The medical devices segment is estimated to witness significant growth during the forecast period. The medical devices market encompasses instruments, apparatus, appliances, materials, and articles utilized for disease diagnosis, prevention, monitoring, treatment, and relief. Major categories include therapeutic and surgical devices, patient monitoring and diagnostic devices (PMDMIDs), and other medical devices. Factors fueling market expansion include the increasing disease prevalence and related risk factors, an aging population, public and private initiatives to promote health awareness, and escalating healthcare expenditures. For instance, the European Union is projected to have approximately 22.4% of its population aged 65 and above by 2024. Quality control is a critical aspect of medical devices, ensuring their safety and effectiveness.

Robotics in surgery and minimally invasive procedures enhance precision and reduce complications. Medical billing and insurance claims processing streamline financial transactions. Medical lasers, pharmaceutical research, and drug delivery systems advance treatment modalities. Health informatics, rem

Snapshot img

Medical Transcription Market Size 2024-2028

The medical transcription market size is forecast to increase by USD 28.63 billion at a CAGR of 6.55% between 2023 and 2028.

The market is experiencing significant growth due to several key trends. The increasing demand for automated transcripts is driving market growth, as healthcare providers seek to streamline their workflows and reduce turnaround times. Additionally, the emergence of advanced voice recognition technologies is enabling more accurate and efficient transcription, further fueling market expansion. However, concerns for medical data privacy remain a challenge, as the handling of sensitive patient information requires stringent security measures. Adherence to regulatory compliance and data protection standards is crucial for market participants to maintain trust and credibility with their clients. Moreover, AI, machine learning, and data-driven technologies have revolutionized clinical documentation, enabling healthcare professionals, including radiologists, clinicians, and surgeons, to access patient information more efficiently. Urbanization and the increasing adoption of telemedicine services and telehealth have further expanded the market's reach. Overall, the market is poised for continued growth, driven by these trends and the need for efficient, accurate, and secure transcription solutions.

What will be the Size of the Medical Transcription Market During the Forecast Period?

Request Free Sample

The medical transcription (MT) market encompasses the conversion of spoken or handwritten medical documentation into text format, serving a vital role in healthcare facilities, clinics, and physicians' offices worldwide. This market is driven by the increasing volume of patient data generated from chronic illnesses such as melanoma, cardiovascular problems, and diabetes. The growing reliance on electronic health records (EHRs) and the need for ADT normalization and audio identification have fueled market expansion. Urbanization and the adoption of encryption technologies have increased the security of patient information, enabling the use of over-the-counter drugs and telemedicine services in MT processes. Telehealth and AI technologies, including machine learning, have revolutionized medical examination findings analysis and treatment plan development, reducing staff burden and streamlining patient forms and discharge summaries.
These trends are expected to continue shaping the dynamic and growing the market.

How is this Medical Transcription Industry segmented and which is the largest segment?

The medical transcription industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Hospitals
  Physician groups and clinics


Type

  Services
  Software


Geography

  North America

    Canada
    US


  APAC

    Japan


  Europe

    Germany
    UK


  South America



  Middle East and Africa

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period.

Medical transcription (MT) plays a crucial role In the efficient management of healthcare documentation for hospitals, healthcare facilities, clinics, and physicians. With the rise of chronic illnesses such as melanoma, cardiovascular problems, and diabetes, the need for accurate and timely clinical documentation has become increasingly important. MT enables the conversion of spoken words into written records, facilitating the creation of treatment records, medical examination findings, and treatment plans. Advancements in technology, including audio identification, voice capture, and voice recognition, have streamlined the MT process.

Data security mechanisms, such as encryption technologies and regulatory requirements, ensure the protection of confidential patient information from data breaches and ransomware attacks. EHR manufacturers continue to invest in MT solutions, integrating them with cloud/web-based and on-premises/installed systems. Capital expenditures on healthcare IT are projected to grow, driving the market's expansion. Operational efficiency, patient care, and treatment plans are key benefits of MT, which is essential for healthcare providers to meet the demands of an increasing patient population and staff burden.

Patient forms, discharge summaries, and patient history are some of the critical documents that can be processed through MT, ensuring accurate and timely documentation. The market is expected to grow steadily due to these factors and the increasing prevalence of chronic diseases, including cancer, diabetes, and cardiovascular diseases.

Get a glance at the Medical Transcription Industry report of share of various segments Request F

Snapshot img

Chronic Disease Management Market Size 2025-2029

The chronic disease management market size is forecast to increase by USD 5.66 billion, at a CAGR of 11.2% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing geriatric population and the prevalence of chronic diseases. With an aging population comes a higher incidence of chronic conditions, such as diabetes, cardiovascular diseases, and cancer, necessitating effective management solutions. Technological advancements are playing a pivotal role in this market, enabling remote monitoring, telehealth, and data analytics, which improve patient outcomes and reduce healthcare costs. However, challenges persist in the form of medical data privacy concerns. As the digitalization of health data continues, ensuring its security and confidentiality becomes increasingly important to mitigate potential risks and maintain patient trust. Companies seeking to capitalize on market opportunities must prioritize innovation, data security, and regulatory compliance to meet the evolving needs of patients and healthcare providers.

What will be the Size of the Chronic Disease Management Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market continues to evolve, driven by advancements in technology and shifting healthcare priorities. Integral components of this dynamic landscape include machine learning algorithms, interoperability standards, medication adherence tracking, healthcare payers, data security protocols, risk stratification models, and personalized treatment plans. These elements are seamlessly integrated into various sectors, such as diabetes management tools, data analytics dashboards, virtual care consultations, population health management, remote patient monitoring, lifestyle modification programs, telemedicine platforms, mobile health applications, health coaching services, respiratory disease management, predictive modeling, pain management solutions, remote therapeutic monitoring, clinical trials management, patient engagement tools, healthcare IoT devices, AI-powered diagnostics, mental health platforms, behavioral interventions, wearable sensors, oncology care management, and cardiovascular disease management. The ongoing unfolding of market activities reveals a focus on improving patient outcomes through innovative solutions. For instance, machine learning algorithms are employed to analyze vast amounts of data, enabling early detection and intervention. Interoperability standards ensure seamless data exchange between different systems, enhancing care coordination. Medication adherence tracking helps manage chronic conditions more effectively, reducing hospitalizations and improving patient satisfaction. Healthcare payers are increasingly adopting value-based care models, which incentivize providers to deliver high-quality care while managing costs. Data security protocols are strengthened to protect sensitive patient information. Risk stratification models help identify high-risk patients, allowing for targeted interventions and personalized treatment plans. Pharmacovigilance systems monitor drug safety, ensuring patient safety and regulatory compliance. The integration of technology in chronic disease management is transforming the industry, with telemedicine platforms and virtual care consultations enabling remote access to care. Remote patient monitoring allows for continuous monitoring of vital signs, while wearable sensors provide real-time data. AI-powered diagnostics enable faster and more accurate diagnoses. Mental health platforms and behavioral interventions address the growing need for holistic care. In conclusion, the market is characterized by continuous evolution, driven by technological advancements and shifting healthcare priorities. The integration of machine learning algorithms, interoperability standards, medication adherence tracking, healthcare payers, data security protocols, risk stratification models, and personalized treatment plans is transforming the industry, improving patient outcomes and enhancing care coordination. This dynamic landscape is shaping the future of chronic disease management, with a focus on innovation, efficiency, and patient-centered care.

How is this Chronic Disease Management Industry segmented?

The chronic disease management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. TypeSolutionsServicesEnd-userHealthcare providersHealthcare payersDisease TypeCardiovascular diseasesDiabetesChronic obstructive pulmonary disordersArthritisOthersGeographyNorth AmericaUSCanadaEuropeFranceGe